HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nestlé Pens $6bn Deal For The Bountiful Company's Core Brands

Executive Summary

Nestlé is poised to add to its Health Science portfolio the Nature's Bounty, Solgar, Osteo Bi-Flex and Puritan’s Pride dietary supplement brands, which generate the majority of their sales in the North American market. 

You may also be interested in...



US FTC Collects First ‘Review Hijacking’ Bounty Against Nestle’s Bountiful Supplement Business

FTC proposes order to settle administrative complaint requiring Bountiful Company to pay $600,000 monetary relief for consumers. Order prohibits the Nestle business from using “variation” relationships in e-commerce ads, when positive reviews posted for one product may be confused with a different but similar product.

People On The Move: Appointments At IADSA, Nestlé, Zambon

A round-up of the latest European consumer health industry appointments: DSM's Gerhard Gans elected chair of the International Alliance of Dietary/Food Supplement Associations; Nestlé Health Science promotes Gordon Yule to lead its UK and Ireland operation; and Zambon hires UCB's Ilaria Villa as its global general manager.

Nestlé Spies APAC Expansion Potential With Deal for New Zealand's Better Health

Nestlé Health Science continues to expand its dietary supplements offering in 2022 penning a deal for New Zealand's The Better Health Company and its GO Healthy brand. The company says the deal will strengthen its presence not just in New Zealand but across the wider APAC region in markets such as Australia and China.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel